Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease

Midbrain dopamine neurons have crucial functions in motor and emotional control and their degeneration leads to several neurological dysfunctions such as Parkinson’s disease, addiction, depression, schizophrenia, and others. Despite advances in the understanding of specific altered proteins and codi...

Full description

Bibliographic Details
Main Authors: Emilia Pascale, Giuseppina Divisato, Renata Palladino, Margherita Auriemma, Edward Faustine Ngalya, Massimiliano Caiazzo
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/9/1269
_version_ 1797554737007034368
author Emilia Pascale
Giuseppina Divisato
Renata Palladino
Margherita Auriemma
Edward Faustine Ngalya
Massimiliano Caiazzo
author_facet Emilia Pascale
Giuseppina Divisato
Renata Palladino
Margherita Auriemma
Edward Faustine Ngalya
Massimiliano Caiazzo
author_sort Emilia Pascale
collection DOAJ
description Midbrain dopamine neurons have crucial functions in motor and emotional control and their degeneration leads to several neurological dysfunctions such as Parkinson’s disease, addiction, depression, schizophrenia, and others. Despite advances in the understanding of specific altered proteins and coding genes, little is known about cumulative changes in the transcriptional landscape of noncoding genes in midbrain dopamine neurons. Noncoding RNAs—specifically microRNAs and long noncoding RNAs—are emerging as crucial post-transcriptional regulators of gene expression in the brain. The identification of noncoding RNA networks underlying all stages of dopamine neuron development and plasticity is an essential step to deeply understand their physiological role and also their involvement in the etiology of dopaminergic diseases. Here, we provide an update about noncoding RNAs involved in dopaminergic development and metabolism, and the related evidence of these biomolecules for applications in potential treatments for dopaminergic neurodegeneration.
first_indexed 2024-03-10T16:36:19Z
format Article
id doaj.art-d89aa34e72444d4b89430b883afb4e2c
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T16:36:19Z
publishDate 2020-09-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-d89aa34e72444d4b89430b883afb4e2c2023-11-20T12:24:48ZengMDPI AGBiomolecules2218-273X2020-09-01109126910.3390/biom10091269Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and DiseaseEmilia Pascale0Giuseppina Divisato1Renata Palladino2Margherita Auriemma3Edward Faustine Ngalya4Massimiliano Caiazzo5Department of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyDepartment of Molecular Medicine and Medical Biotechnology, University of Naples “Federico II”, Via Pansini 5, 80131 Naples, ItalyMidbrain dopamine neurons have crucial functions in motor and emotional control and their degeneration leads to several neurological dysfunctions such as Parkinson’s disease, addiction, depression, schizophrenia, and others. Despite advances in the understanding of specific altered proteins and coding genes, little is known about cumulative changes in the transcriptional landscape of noncoding genes in midbrain dopamine neurons. Noncoding RNAs—specifically microRNAs and long noncoding RNAs—are emerging as crucial post-transcriptional regulators of gene expression in the brain. The identification of noncoding RNA networks underlying all stages of dopamine neuron development and plasticity is an essential step to deeply understand their physiological role and also their involvement in the etiology of dopaminergic diseases. Here, we provide an update about noncoding RNAs involved in dopaminergic development and metabolism, and the related evidence of these biomolecules for applications in potential treatments for dopaminergic neurodegeneration.https://www.mdpi.com/2218-273X/10/9/1269microRNAlong noncoding RNAdopamine neuronsParkinson’s diseasedirect cell conversion or reprogrammingRNA therapeutics
spellingShingle Emilia Pascale
Giuseppina Divisato
Renata Palladino
Margherita Auriemma
Edward Faustine Ngalya
Massimiliano Caiazzo
Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
Biomolecules
microRNA
long noncoding RNA
dopamine neurons
Parkinson’s disease
direct cell conversion or reprogramming
RNA therapeutics
title Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
title_full Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
title_fullStr Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
title_full_unstemmed Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
title_short Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease
title_sort noncoding rnas and midbrain da neurons novel molecular mechanisms and therapeutic targets in health and disease
topic microRNA
long noncoding RNA
dopamine neurons
Parkinson’s disease
direct cell conversion or reprogramming
RNA therapeutics
url https://www.mdpi.com/2218-273X/10/9/1269
work_keys_str_mv AT emiliapascale noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease
AT giuseppinadivisato noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease
AT renatapalladino noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease
AT margheritaauriemma noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease
AT edwardfaustinengalya noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease
AT massimilianocaiazzo noncodingrnasandmidbraindaneuronsnovelmolecularmechanismsandtherapeutictargetsinhealthanddisease